Sit Investment Associates Inc Biomarin Pharmaceutical Inc Transaction History

Sit Investment Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $1.69 Million - $3.08 Million	23,500 New	23,500 $1.79 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $1.69 Million - $3.08 Million	-23,500 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$71.37 - $96.85 $228,384 - $309,920	3,200 Added 15.76%	23,500 $1.99 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $1.3 Million - $1.75 Million	20,300 New	20,300 $1.72 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.